FDA•
0.9% Sodium Chloride Injection, USP, 100 mL Partial Fill
B. Braun recalls 0.9% Sodium Chloride Injection, 100 mL Partial Fill, due to particulate matter (iron oxide, cellulose, polystyrene).
Filters
Category
Agency
Severity
Date
Distributed in
Drugs Recalls
Back to home ←
FDA•fentaNYL Citrate Injection 1,000 mcg/100 mLOurPharma recalls fentaNYL Citrate Injection 1,000 mcg/100 mL over mislabeled expiry dates; NDC 73013-1013-01.
FDA•Epinephrine Injection 30 mg/30 mLAmerican Regent recalls epinephrine 30 mg/30 mL vials due to glass particulates and sterility concerns.
FDA•2% Chlorhexidine Gluconate ClothsSage Products recalls 2% Chlorhexidine Gluconate Cloths over possible cross-contamination.
FDA•Buprenorphine Sublingual Tablets 2 mgAmerican Health Packaging recalls Buprenorphine Sublingual Tablets 2 mg over a label mix-up.
FDA•Prasugrel HCl 10mg TabletsGSMS recalls Prasugrel HCl 10mg tablets over failed dissolution specs.
FDA•Revcovi (elapegademase-lvlr) InjectionChiesi USA recalls Revcovi ( elapegademase-lvlr) Injection over failed stability specifications.
FDA•Baxter 0.9% Sodium Chloride Injection 500 mLBaxter recalls 0.9% Sodium Chloride Injection 500 mL VIAFLEX bags over fiberglass particulate contamination.
FDA•Glutathione 200 mg/mL Sterile Multidose VialsOptimal Balance Pharmacy recalls Glutathione 200 mg/mL vials over bacterial endotoxin contamination.